• AJMCAJMC
  • Center for Biosimilars
Center for Biosimilars®
Center for Biosimilars®
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Clinical
Dermatology
Endocrinology
Gastroenterology
Legal
Neurology
Oncology
Ophthalmology
Rare Disease
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Polls
Subscribe
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2021 MJH Life Sciences and Center for Biosimilars®. All rights reserved.

Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.

Regulation, Policy, and Litigation in Biosimilars

EP 1: Biosimilar Interchangeability and Market Share

EP 2: Interchangeability and Rheumatology Prescribing Practices

EP 3: Biosimilars, Interchangeability, and Perceptions of Safety

EP 4: Global Reference Products in Biosimilar Development

EP 5: Inspection Reports and Proprietary Information

EP 6: Reforms at the FDA Level

EP 7: Biosimilars, Formularies, Contracting, and PBMs

EP 8: Biosimilar Uptake and Health Plans

EP 9: CMS and Blended Reimbursement Codes

EP 10: Healthcare Reform Efforts and the BPCIA

EP 11: State Laws and Biosimilar Substitution

EP 12: The PTAB's Role in Biosimilar Patent Disputes

EP 13: The Need for Clarity After Sandoz v Amgen

EP 14: Upcoming Patent Litigation in Biosimilars

EP 15: Challenges Ahead for Biosimilars